Lifeboat Foundation

This is one of the first articles I’ve seen specifically on #Judiasm and #transhumaism, with input by rabbis. Naturally the article is cautious, but interesting too.

Transhumanism, an intellectual and cultural movement supporting the use of science and technology to improve human mental and physical characteristics and capacities, a concept once limited to the realm of science-fiction, is now becoming more of a reality than ever before. The once outlier philosophy is quickly becoming mainstream, an accepted part of the social conscience that is the new religion for the anti-religious, including its own Messianic vision.

There are many aspects to the transhumanism philosophy, often abbreviated as H+ or h+, including physical longevity through medical breakthroughs and/or merging mankind with machines. Many transhumanists advocate transferring the sum total of a person’s knowledge and experiences into a computer and recreating the individual as a form of artificial intelligence ( AI ) in order to extend an individual’s life.

Continue reading “Synergy Between Torah and Science: How Far is TOO Far?” »

Rudrapur, Uttrakhand, India — July 02, 2017

Revita Life Sciences, (http://revitalife.co.in) a biotechnology company focused on translational regenerative therapeutic applications, has announced that it is continuing to advance their novel, multi-modality clinical intervention in the state of brain death in humans.

“We have proactively continued to advance our multi-modality protocol, as an extended treatment before extubation, in an attempt to reverse the state of brain death” said Mr.Pranjal Agrawal, CEO Revita Life Sciences. “This treatment approach has yielded some very encouraging initial outcome signs, ranging from minor observations on blood pressure changes with response to painful stimuli, to eye opening and finger movements, with corresponding transient to permanent reversal changes in EEG patterns.”

Continue reading “Revita Life Sciences Continues to Advance Multi-Modality Protocol in Attempt to Revive Brain Dead Subjects” »

The June Journal Club video is now available for your viewing pleasure. Dr. Oliver Medvedik talks about telomeres and cellular reprogramming in this latest edition of our new live streamed monthly show.

It has been a busy few months since we launched our Lifespan Heroes campaign on Lifespan.io the aim of which is to help us expand the scale and scope of our activities.

Continue reading “Journal Club June 2017 Video Available” »

Gearing up for clinical trials.

Liz discusses how we can overcome the limits on human health and lifespan; elaborating on BioViva’s role as a translational engine to provide access to cutting-edge therapies for those most in need.

http://journey100.org | Journey to 100 is a world-exclusive conference exploring ideas for a new and sustainable approach to lifelong health. The day kick starts a 10-year project that aims to make Guernsey the first community in the world to break through the 100-year life expectancy barrier.

Continue reading “BioViva at Journey to 100” »

Keith Comito introduces the Lifespan Heroes campaign and how we as a community can support the development of new therapies to treat age-related diseases for a healthier and longer life.

Link to the Lifespan Heroes campaign: https://www.lifespan.io/campaigns/join-us-become-a-lifespan-hero/

Link to all our campagins: https://www.lifespan.io

The perceived inevitability of death often pushes us to try to find meaning in it. In this article, I discussed why I think this has at least partly contributed to the cliché that death gives meaning to life.

The point of this blog is to advocate for rejuvenation therapies. In principle, it could be written without ever typing the word ‘death’, because rejuvenation is about keeping people healthy, and the indefinite postponement of death is merely a possible consequence of constant good health. In this sense, this and many other posts and articles on Rejuvenaction could be considered off-topic. However, it is not uncommon for people to accept, rather uncritically, the stale cliché according to which life gets its meaning from death, and without the latter, it would not have meaning. If rejuvenation can stave off death and extend lives indefinitely, will these extended lives be utterly meaningless?

No. Time and time again have I said this before, but I still fear that this misconception may be one of the worst enemies of rejuvenation; consequently, I spend much time thinking about its roots and how to debunk it.

Whether life gets its meaning from death or not, people who think it does implicitly admit that life has no meaning per se. In a general sense, this is correct. Life is meaningless, and there’s nothing wrong with it. It is no reason to be depressed, and I have explained why many times: Meaning is not an intrinsic property of anything. To paraphrase a common adage, meaning lies in the head of the beholder, and that’s where you should expect to find the meaning—if any—of anything, life included. In other words, it is up to you to find meaning in your life, and you should neither expect it to have meaning by default, nor let others decide for you what the meaning of your life is. This applies to everything else too. Whenever the meaning of X is being discussed, one should always ask to whom X means what, or who meant what when they did or said X. It goes without saying that, just like life, death has no intrinsic meaning either.

This is the oldest and largest art magazine by circulation in the world. For the first time, it has #transhumanism in its search engines. A main task of mine all these years has been spreading that word and concept. My talk at #Moogfest on the Immortality Bus is covered a bit in this story.

L ast month, as bidding was underway at Sotheby’s for what would prove to be a stratospheric Jean-Michel Basquiat sale, Lonnie Holley, a 67-year-old artist who was born in Birmingham, Alabama, and has worked for decades in various folksy and homegrown modes, was preparing to take the stage at a sports bar in Durham, North Carolina. He was sitting at a table in the back, in a place that stank of burgers and beer. An audience of a few dozen had convened for the occasion, though it was hard to distinguish between Holley fans and regular denizens of the Bullpen, a joint next door to the stadium for the beloved local minor-league baseball team, the Durham Bulls. Night-game lights were bright outside. Televisions above the bar showed the Bulls making easy work of the Gwinnett Braves, in town for a weekend series from Georgia. The air was thick and languid in the way it tends to be on a deep, hot Southern summer night.

Holley is a hero to some: as an artist, he has made formidable paintings and sculptures that have been collected by the Souls Grow Deep Foundation and exhibited by museums and institutions all over, and as a musician, he has forged an unforgettable sound with a stirring voice and stewing electronics. For all his accomplishments, though, Holley remains underappreciated—certainly not as known in the worlds of either art or music as he should be.

Continue reading “For Moogfest, Michael Stipe, Lonnie Holley, and Transhuman Futurists Commune Down South” »

Philadelphia, PA, USA / Moscow, Russia — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, and Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, announced a multi-disciplinary research collaboration with the FSBI Zakusov Institute of Pharmacology, Russian Academy of Medical Sciences (http://www.academpharm.ru/), and the Pavlov Institute of Physiology of the Russian Academy of Sciences (http://www.infran.ru/), to jointly study the pharmacotherapeutic longevity enhancement properties of its combinatorial regenerative biologic candidates.

“We are very excited about this continued collaboration with Lakmus,” said Ira S. Pastor, CEO, Bioquark Inc. “The disciplined development of our combinatorial biologic candidates (Bioquantines) for healthy longevity enhancement, represents another important step in our continued evolution as a company focused on a broad range of therapeutic products and services in the regenerative healthcare space.”

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

Continue reading “Bioquark Inc. and Lakmus LLC Announce Research Collaboration to Study Novel Biopharmaceuticals for Healthy Longevity Enhancement” »

Today live from Cooper Union, NYC, the June edition of Journal Club is being broadcast on our Facebook page at 13:00 EST / 18:00 UK.

We are discussing the recent paper “Common Telomere Changes during In Vivo Reprogramming and Early Stages of Tumorigenesis.” by Blaso et al.

Tune in today and get involved in the discussion. Journal Club is made possible thanks to the support of our Lifespan Heroes.